Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Leifer

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
JACC. Heart Failure|October 17, 2017
The Risks and Benefits of Moderate Alcohol Consumption: There Remains Much to LearnEric S Leifer
Biometrics|April 5, 2019
Discussion of "A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III" by Andrew G. Chapple and Peter F. ThallEric S Leifer, Nancy L Geller
Contemporary Clinical Trials|June 6, 2006
Comparison of two or more measurement techniques to a standardMichael A Proschan, Eric S Leifer
JACC. Heart Failure|October 11, 2020
Patient-Centered Measures of Treatment BenefitEric S Leifer, Robert J Mentz
JACC. Cardiovascular Imaging|May 6, 2017
The Authors ReplyAndrew E Arai, Eric S Leifer, Vandana Sachdev
Statistics in Medicine|May 1, 2018
Dealing with competing risks in clinical trials: How to choose the primary efficacy analysis?James F Troendle, Eric S Leifer, Lauren Kunz
Clinical Trials (London, England)|August 19, 2021
Joint testing of overall and simple effects for the two-by-two factorial trial designEric S Leifer, James F Troendle, Alexis Kolecki, et al.
Statistics in Medicine|October 7, 2025
Sensitivity Analyses for Missing in Repeatedly Measured Outcome DataJames F Troendle, Aparajita Sur, Eric S Leifer, et al.
Circulation. Heart Failure|May 15, 2025
Hierarchical Analysis of Composite Time-to-Event End Points in Heart Failure Clinical Trials Using Time in Clinical StateEric S Leifer, James F Troendle, Mitchell A Psotka, et al.
Pediatric Cardiology|April 14, 2011
Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic eventsJeffrey P Moak, Eric S Leifer, Dorothy Tripodi, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
JACC. Heart Failure|October 17, 2017
The Risks and Benefits of Moderate Alcohol Consumption: There Remains Much to LearnEric S Leifer
Biometrics|April 5, 2019
Discussion of "A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III" by Andrew G. Chapple and Peter F. ThallEric S Leifer, Nancy L Geller
Contemporary Clinical Trials|June 6, 2006
Comparison of two or more measurement techniques to a standardMichael A Proschan, Eric S Leifer
JACC. Heart Failure|October 11, 2020
Patient-Centered Measures of Treatment BenefitEric S Leifer, Robert J Mentz
JACC. Cardiovascular Imaging|May 6, 2017
The Authors ReplyAndrew E Arai, Eric S Leifer, Vandana Sachdev
Statistics in Medicine|May 1, 2018
Dealing with competing risks in clinical trials: How to choose the primary efficacy analysis?James F Troendle, Eric S Leifer, Lauren Kunz
Clinical Trials (London, England)|August 19, 2021
Joint testing of overall and simple effects for the two-by-two factorial trial designEric S Leifer, James F Troendle, Alexis Kolecki, et al.
Statistics in Medicine|October 7, 2025
Sensitivity Analyses for Missing in Repeatedly Measured Outcome DataJames F Troendle, Aparajita Sur, Eric S Leifer, et al.
Circulation. Heart Failure|May 15, 2025
Hierarchical Analysis of Composite Time-to-Event End Points in Heart Failure Clinical Trials Using Time in Clinical StateEric S Leifer, James F Troendle, Mitchell A Psotka, et al.
Pediatric Cardiology|April 14, 2011
Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic eventsJeffrey P Moak, Eric S Leifer, Dorothy Tripodi, et al.
Pageof 7